SLC5A5 and cholangiocarcinoma: The presence of the NIS on the basal membrane of certain tumor cells, such as those in DTC, cholangiocarcinoma and hepatocellular carcinoma, facilitates iodine uptake and forms the basis for radioiodine therapy (35).